Post-Ingestion Blood Hydrogen Kinetics Following Oral Hydrogen-Rich Water Intake in Healthy Adults: A Pilot Pharmacokinetic Study.

Authors

David Nedeljkovic, Nikola Todorovic, Dejan Javorac, Bogdan Andjelic, Milan Vranes, Sergej M Ostojic

Published in

Current reviews in clinical and experimental pharmacology. Oct 07, 2026. Epub Oct 07, 2026.

Abstract

Molecular hydrogen (H2) has gained attention as a therapeutic agent due to its antioxidant and anti-inflammatory properties. However, human Pharmacokinetic (PK) data remain limited, particularly for Hydrogen-Rich Water (HRW). This study aimed to characterize blood hydrogen kinetics following oral HRW intake in healthy adults.
Twelve healthy participants (mean age 28.8 ± 3.8 years; BMI 23.4 ± 3.2 kg/m²; 50% female) were enrolled in the study. After an overnight fast, participants consumed a single dose of HRW. Blood samples were collected at baseline and at multiple time points up to 120 minutes postingestion. Hydrogen concentrations were measured using a Clark-type microsensor. PK parameters were calculated using non-compartmental analysis, and time-dependent changes were assessed using linear mixed-effects modeling.
Baseline hydrogen concentration was 0.25 ± 0.05 μg/L. Peak concentration (Cmax) reached 0.83 ± 0.18 μg/L at 42.9 ± 8.4 minutes (Tmax). The elimination half-life was 144.8 ± 41.7 minutes, and total systemic exposure (AUC₀-∞) was 128.6 ± 27.1 μg/L·min. Hydrogen levels were significantly elevated at 15, 60, and 90 minutes compared to baseline. Notable inter-individual variability was observed, and no sex-related differences were detected.
Oral HRW intake resulted in measurable systemic hydrogen exposure, with a biphasic concentration pattern, suggesting rapid absorption possibly followed by redistribution. Observed concentrations approached proposed minimal effective levels but were not sustained, raising questions about optimal dosing strategies.
HRW ingestion produces detectable and biologically relevant increases in blood hydrogen levels. These findings support HRW as a viable route of H2 administration and provide a foundation for future studies investigating dosing, kinetics, and therapeutic applications.

PMID:
42865187
Bibliographic data and abstract were imported from PubMed on 13 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.